Jefferies Lifts PT on Integra LifeSciences (IART) to $46
Jefferies bumped
its price target on Buy-rated Integra LifeSciences (NASDAQ: IART) from $43 to $46 following Q4 results.
The ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
its price target on Buy-rated Integra LifeSciences (NASDAQ: IART) from $43 to $46 following Q4 results.The ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)